Guided Therapeutics, Inc. (GTHP)

Market Cap	26.66M +157.0%
Revenue (ttm)	178.00K +368.4%
Net Income	-2.80M
EPS	-0.05
Shares Out	91.92M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	35,000
Average Volume	13,023
Open	0.2900
Previous Close	0.2880
Day's Range	0.2900 - 0.2900
52-Week Range	0.0644 - 0.5400
Beta	0.56
RSI	44.13
Earnings Date	Mar 27, 2026

About Guided Therapeutics

Guided Therapeutics, Inc., a medical technology company, develops medical devices. It focuses on the marketing and sale of LuViva, an advanced cervical scan non-invasive cervical cancer detection device that identifies cervical cancers and precancers painlessly, non-invasively, and at the point-of-care by scanning the cervix with light, then analyzing the light reflected and fluorescent light. The company was formerly known as SpectRx, Inc. and changed its name to Guided Therapeutics, Inc. in February 2008. Guided Therapeutics, Inc. was incorpo...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1992
• Employees: 4
• Stock Exchange: OTCMKTS
• Ticker Symbol: GTHP

Financial Performance

In 2024, Guided Therapeutics's revenue was $7,000, a decrease of -92.86% compared to the previous year's $98,000. Losses were -$2.59 million, -31.07% less than in 2023.